Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

Efectos neuroendocrinos de la hiperprolactinemia: enfoque en los sistemas de dopamina y serotonina

  • 0Department of Pharmacology, College of Pharmaceutical Sciences, Dayananda Sagar University, Harohalli, Bengaluru South, Karnataka-562112, India.

|

|

Resumen

Este resumen es generado por máquina.

Los niveles altos de prolactina (hiperprolactinemia) interrumpen los neurotransmisores cerebrales, afectando el estado de ánimo y el comportamiento. Los sistemas de dopamina y serotonina se ven particularmente afectados, lo que puede conducir a trastornos neuropsiquiátricos.

Área De La Ciencia

  • Neuroendocrinología
  • Neurofarmacología
  • La psiquiatría

Sus Antecedentes

  • La hiperprolactinemia implica niveles elevados de prolactina, que afectan las funciones reproductivas.
  • La prolactina influye significativamente en los sistemas neurotransmisores del cerebro, afectando el estado de ánimo, el comportamiento y la cognición.

Objetivo Del Estudio

  • Revisar la relación entre la hiperprolactinemia y la neurotransmisión.
  • Para enfatizar el impacto en los sistemas dopaminérgico y serotoninérgico.
  • Para explorar la importancia clínica y las estrategias de tratamiento.

Principales Métodos

  • Revisión de la literatura centrada en la hiperprolactinemia y las interacciones con los neurotransmisores.
  • Análisis de los efectos de la prolactina en los sistemas de dopamina, serotonina, GABA y glutamato.
  • Evaluación de la interacción de la prolactina con las hormonas sexuales.

Principales Resultados

  • El aumento de la prolactina interrumpe la señalización dopaminérgica, causando potencialmente depresión y psicosis.
  • La hiperprolactinemia afecta negativamente el sistema serotoninérgico, empeorando los trastornos del estado de ánimo.
  • Las interacciones con otros sistemas de neurotransmisores y hormonas sexuales contribuyen a los efectos neuropsiquiátricos.

Conclusiones

  • La hiperprolactinemia está relacionada con varias afecciones neuropsiquiátricas debidas a desequilibrios de los neurotransmisores.
  • Los agonistas de la dopamina son una estrategia de tratamiento actual.
  • La investigación futura debería explorar nuevas terapias dirigidas a los sistemas de neurotransmisores.

Videos de Conceptos Relacionados

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists 01:28

593

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...

Drugs Affecting Neurotransmitter Synthesis 01:29

1.6K

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...

Major Hormones and Their Functions 01:27

678

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists 01:23

395

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...

Parkinson's Disease: Treatment 01:24

376

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists 01:29

439

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...